Chronic (Inactive) Thyroid Eye Disease: Clinical Trials

1 trial for Chronic (Inactive) Thyroid Eye Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Chronic (Inactive) Thyroid Eye Disease: new trials by email Literature Review of Chronic (Inactive) Thyroid Eye Disease trials Research Report on Chronic (Inactive) Thyroid Eye Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
TEPEZZA, Placebo - Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease
Phase 4CompletedAmgen622021-09-022024-07-01

Narrower conditions

Bronchiolitis Obliterans Syndrome (1)  ·  Exophthalmos (1)  ·  Graves Ophthalmopathy (1)  ·  Sedentary Behavior (1)

Broader conditions

Autoimmune Diseases (1)  ·  Behavior (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine System Diseases (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Goiter (1)  ·  Graft vs Host Disease (1)  ·  Graves Disease (1)  ·  Hyperthyroidism (1)

Interventions

Sodium Chloride (1)  ·  teprotumumab (1)

Sponsors

Amgen (1)

Countries

United States (1)

Results publications

PMID 42837042